Newsbenzinga
McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization
· Published
Article summary
McKesson will acquire Precision Medicine Group for $2.25 billion, expanding its clinical research and drug commercialization services.
An excerpt from the original article.
Comments —
Loading comments…